Ramucirumab treatment in hepatocellular carcinoma

Chin Clin Oncol. 2020 Dec;9(6):83. doi: 10.21037/cco.2019.12.18. Epub 2020 Jan 8.

Authors

Federico Longo¹, Alfredo Carrato²

Affiliations

¹ Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University, Madrid, Spain. fedelongomunoz@hotmail.com.
² Medical Oncology Department, Ramón y Cajal University Hospital, IRYCIS, CIBERONC, Alcalá University, Madrid, Spain.

PMID: 32008334
DOI: 10.21037/cco.2019.12.18

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy
Ramucirumab

Substances

Antibodies, Monoclonal, Humanized